Literature DB >> 26351338

Epidemiology of Human Papillomavirus-Positive Head and Neck Squamous Cell Carcinoma.

Maura L Gillison1, Anil K Chaturvedi2, William F Anderson2, Carole Fakhry2.   

Abstract

Human papillomavirus (HPV) is now established as the principal cause of an increase in incidence of a subset of head and neck squamous cell cancers (HNCs) in numerous geographic regions around the world. Further study of the epidemiology of HPV-positive HNC will be critical to the development and implementation of public health interventions to reverse these global incidence trends. Here, recent data are reviewed to provide insight into several topics, including incidence trends and projections for HPV-positive HNC; the worldwide HPV-attributable fraction; sex disparities in cancer risk; the epidemiology of oral HPV infection; the latency period between infection and cancer; the potential impact of prophylactic HPV vaccination; and prospects for secondary prevention through screening for oral HPV infection or seroreactivity to viral antigens. The identification of a single necessary cause for any cancer provides a rare and perhaps extraordinary opportunity for cancer prevention.
© 2015 by American Society of Clinical Oncology.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26351338      PMCID: PMC4979086          DOI: 10.1200/JCO.2015.61.6995

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN: 0732-183X            Impact factor:   44.544


  66 in total

1.  Sexual transmission of oral human papillomavirus infection among men.

Authors:  Kristina R Dahlstrom; Ann N Burchell; Agnihotram V Ramanakumar; Allita Rodrigues; Pierre-Paul Tellier; James Hanley; François Coutlée; Eduardo L Franco
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2014-11-12       Impact factor: 4.254

Review 2.  EUROGIN 2014 roadmap: differences in human papillomavirus infection natural history, transmission and human papillomavirus-related cancer incidence by gender and anatomic site of infection.

Authors:  Anna R Giuliano; Alan G Nyitray; Aimée R Kreimer; Christine M Pierce Campbell; Marc T Goodman; Staci L Sudenga; Joseph Monsonego; Silvia Franceschi
Journal:  Int J Cancer       Date:  2014-07-26       Impact factor: 7.396

3.  Low etiologic fraction for high-risk human papillomavirus in oral cavity squamous cell carcinomas.

Authors:  Mark W Lingen; Weihong Xiao; Alessandra Schmitt; Bo Jiang; Robert Pickard; Paul Kreinbrink; Bayardo Perez-Ordonez; Richard C Jordan; Maura L Gillison
Journal:  Oral Oncol       Date:  2012-07-28       Impact factor: 5.337

4.  Rates and determinants of oral human papillomavirus infection in young men.

Authors:  Zoe R Edelstein; Stephen M Schwartz; Stephen Hawes; James P Hughes; Qinghua Feng; Michael E Stern; Sandra O'Reilly; Shu-Kuang Lee; Long Fu Xi; Laura A Koutsky
Journal:  Sex Transm Dis       Date:  2012-11       Impact factor: 2.830

Review 5.  Clinical trials of human papillomavirus vaccines and beyond.

Authors:  Matti Lehtinen; Joakim Dillner
Journal:  Nat Rev Clin Oncol       Date:  2013-06-04       Impact factor: 66.675

6.  Eurogin Roadmap: comparative epidemiology of HPV infection and associated cancers of the head and neck and cervix.

Authors:  Maura L Gillison; Xavier Castellsagué; Anil Chaturvedi; Marc T Goodman; Peter Snijders; Massimo Tommasino; Marc Arbyn; Silvia Franceschi
Journal:  Int J Cancer       Date:  2013-08-05       Impact factor: 7.396

Review 7.  Global burden of cancers attributable to infections in 2008: a review and synthetic analysis.

Authors:  Catherine de Martel; Jacques Ferlay; Silvia Franceschi; Jérôme Vignat; Freddie Bray; David Forman; Martyn Plummer
Journal:  Lancet Oncol       Date:  2012-05-09       Impact factor: 41.316

8.  Human papillomavirus prevalence in oropharyngeal cancer before vaccine introduction, United States.

Authors:  Martin Steinau; Mona Saraiya; Marc T Goodman; Edward S Peters; Meg Watson; Jennifer L Cleveland; Charles F Lynch; Edward J Wilkinson; Brenda Y Hernandez; Glen Copeland; Maria S Saber; Claudia Hopenhayn; Youjie Huang; Wendy Cozen; Christopher Lyu; Elizabeth R Unger
Journal:  Emerg Infect Dis       Date:  2014-05       Impact factor: 6.883

9.  Cost-effectiveness of female human papillomavirus vaccination in 179 countries: a PRIME modelling study.

Authors:  Mark Jit; Marc Brisson; Allison Portnoy; Raymond Hutubessy
Journal:  Lancet Glob Health       Date:  2014-06-09       Impact factor: 26.763

10.  Prevalence of human papillomavirus in oropharyngeal squamous cell carcinoma in the United States across time.

Authors:  Andrew P Stein; Sandeep Saha; Menggang Yu; Randall J Kimple; Paul F Lambert
Journal:  Chem Res Toxicol       Date:  2014-04-02       Impact factor: 3.739

View more
  324 in total

1.  HPV vaccination to prevent cervical cancer and other HPV-associated disease: from basic science to effective interventions.

Authors:  Douglas R Lowy
Journal:  J Clin Invest       Date:  2016-01-04       Impact factor: 14.808

Review 2.  [Human papillomavirus and squamous cell cancer of the head and neck region : Prognostic, therapeutic and prophylactic implications].

Authors:  M Reuschenbach; S Wagner; N Würdemann; S J Sharma; E-S Prigge; M Sauer; A Wittig; C Wittekindt; M von Knebel Doeberitz; J P Klussmann
Journal:  HNO       Date:  2016-07       Impact factor: 1.284

3.  Intensity Modulated Proton Therapy Versus Intensity Modulated Photon Radiation Therapy for Oropharyngeal Cancer: First Comparative Results of Patient-Reported Outcomes.

Authors:  Terence T Sio; Huei-Kai Lin; Qiuling Shi; G Brandon Gunn; Charles S Cleeland; J Jack Lee; Mike Hernandez; Pierre Blanchard; Nikhil G Thaker; Jack Phan; David I Rosenthal; Adam S Garden; William H Morrison; C David Fuller; Tito R Mendoza; Radhe Mohan; Xin Shelley Wang; Steven J Frank
Journal:  Int J Radiat Oncol Biol Phys       Date:  2016-02-18       Impact factor: 7.038

Review 4.  Eurogin Roadmap 2015: How has HPV knowledge changed our practice: Vaccines.

Authors:  Julia M L Brotherton; Mark Jit; Patti E Gravitt; Marc Brisson; Aimée R Kreimer; Sara I Pai; Carole Fakhry; Joseph Monsonego; Silvia Franceschi
Journal:  Int J Cancer       Date:  2016-03-22       Impact factor: 7.396

5.  Evaluating the Utility and Prevalence of HPV Biomarkers in Oral Rinses and Serology for HPV-related Oropharyngeal Cancer.

Authors:  Gypsyamber D'Souza; Gwendolyn Clemens; Tanya Troy; Rachel G Castillo; Linda Struijk; Tim Waterboer; Noemi Bender; Phillip M Pierorazio; Simon R Best; Howard Strickler; Dorothy J Wiley; Robert I Haddad; Marshall Posner; Carole Fakhry
Journal:  Cancer Prev Res (Phila)       Date:  2019-08-16

Review 6.  Psychosocial Issues in Patients with Head and Neck Cancer: an Updated Review with a Focus on Clinical Interventions.

Authors:  Joshua D Smith; Andrew G Shuman; Michelle B Riba
Journal:  Curr Psychiatry Rep       Date:  2017-09       Impact factor: 5.285

Review 7.  HPV-related oropharyngeal cancer: a review on burden of the disease and opportunities for prevention and early detection.

Authors:  Mary Roz Timbang; Michael W Sim; Arnaud F Bewley; D Gregory Farwell; Avinash Mantravadi; Michael G Moore
Journal:  Hum Vaccin Immunother       Date:  2019-05-07       Impact factor: 3.452

Review 8.  Deintensification of treatment for human papillomavirus-related oropharyngeal cancer: Current state and future directions.

Authors:  Elaine O Bigelow; Tanguy Y Seiwert; Carole Fakhry
Journal:  Oral Oncol       Date:  2020-04-02       Impact factor: 5.337

9.  Social media use and human papillomavirus awareness and knowledge among adults with children in the household: examining the role of race, ethnicity, and gender.

Authors:  Yuki Lama; Sandra Crouse Quinn; Xiaoli Nan; Raul Cruz-Cano
Journal:  Hum Vaccin Immunother       Date:  2020-10-29       Impact factor: 3.452

10.  Human Papillomavirus-Related Oral Cancer: Knowledge and Awareness Among Spanish Dental Students.

Authors:  Alejandro Ismael Lorenzo-Pouso; Pilar Gándara-Vila; Cristina Banga; Mercedes Gallas; Mario Pérez-Sayáns; Abel García; Ellen M Daley; Iria Gasamáns
Journal:  J Cancer Educ       Date:  2019-08       Impact factor: 2.037

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.